Document Classification

Section Type: RESULTS

Text: There were significant improvements with flibanserin versus placebo in the mean (SE) changes in the number of SSEs (1. 0 [0. 1] vs 0. 6 [0. 1]), FSFI desire domain score (0. 7 [0. 1] vs 0. 4 [0. 1]), FSDS-R Item 13 score (-0. 8 [0. 1] vs -0. 6 [0. 1]), FSDS-R total score (-8. 3 [0. 6] vs -6. 3 [0. 6]), and FSFI total score (4. 2 [0. 4] vs 2. 7 [0. 4] ; all P < 0. 01).